Harmony Biosciences (HRMY) · page 165 of 366
The slide uses a 'preempt_rebuttal' strategy by highlighting a specific safety concern (eosinophilic abnormality) that the authors claim was ignored in official FDA review documents.
Research note · preempt_rebuttal · preempt_rebuttal · dense density
Slide locked Sign in to view
Slide schematic 4/4
list 2/2 paragraph 1/1 source-note 1/1
Components 4
bullet bullet paragraph source-note
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.